Support Our Work

Please donate so we can continue our work to reduce the stigma of psychiatric illness, encourage research, and support educational activities for behavioral health professionals and the public. Ways you can donate and help are on our Support and Donations page. Thank you!

More Info

Latest News Around the Web

FDA to revise labeling of ADHD stimulants to warn of pediatric weight loss risk

Reuters (6/30, S K, Singh) reports the FDA said Monday it is “revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings about the risk of weight loss and other side effects in patients under six years old.” The agency stated “that it is requiring a ‘limitation of use’ section in the prescribing information of all extended-release stimulants to include a statement on higher rates of adverse reactions in children younger than six years.”

Related Links:

— “US FDA to revise ADHD stimulants labels to warn of weight loss risk in children under 6,”Sneha S K , Reuters, June 30, 2025

Medicaid Reimbursement Associated With More Billed PPD Screens, Higher Probability Of Mother Being Diagnosed And Treated, Study Finds

MedPage Today (6/30, Robertson ) reports a study found that “Medicaid reimbursement for postpartum depression (PPD) screening at well-child visits may increase detection and treatment of PPD in the first year postpartum.” Researchers utilized adjusted difference-in-differences models and “found that Medicaid reimbursement for maternal depression screening during well-child visits was associated with a 9.6 percentage point increase in the probability of billed depression screens and 18 additional depression screenings per 100 births during those visits.” Furthermore, they observed that “PPD screening reimbursement was associated with a 2.5 percentage point increase in the probability of the mother being diagnosed with a postpartum mood or anxiety disorder, a 3.3 percentage point increase in any outpatient mental health treatment, as well as a 3.3 percentage point decrease in prescription fills for medications for mood or anxiety disorders compared with mothers with commercial insurance.” The study was published in JAMA Pediatrics.Related Links:

— MedPage Today (requires login and subscription)

Regular Exercise Reduces Depression, Anxiety Symptoms In Pediatric Patients, Review Finds

HealthDay (6/30, Thompson ) reports a systemic review and meta-analysis found that “both anxiety and depression decrease when kids take part in structured exercise programs,” which offer “an alternative to medications like antidepressants.” The review “pooled data from 375 prior clinical trials involving more than 38,000 kids 5 to 18.” Researchers observed that “anxiety improved through low-intensity resistance exercise, such as lifting light weights or gentle training using circuit weight machines.” Meanwhile, depression “improved most through moderate-intensity exercise in training that combines aerobic and strength programs.” Furthermore, they found that “the biggest improvements in depression symptoms occurred in programs lasting fewer than three months, suggesting that benefits of exercise can emerge relatively quickly.” In addition, the study found no significant difference between frequency or duration of exercise in improving mental health. The review was published in the Journal of the American Academy of Child & Adolescent Psychiatry.

Related Links:

— “Exercise Helps Kids’ Mood Disorders, Can Serve As Alternative To Meds, Review Finds,”Dennis Thompson, HealthDay, June 30, 2025

Exposure To Traumatic Event More Than Doubles Child’s Risk Of Chronic Absenteeism, Study Finds

HealthDay (6/26, Thompson ) reports a study found that “children who’ve experienced only a single traumatic event are more than twice as likely to be chronically absent from school due to health problems.” The researchers “analyzed data from parents of more than 10,000 children 6 to 17 collected by the 2021-2022 National Health Interview Survey.” They found that children exposed to traumas such as racial or ethnic discrimination, verbal or emotional abuse, or having a parent who is incarcerated, mentally ill, or has a substance use disorder “were 2.4 times more likely to be chronically absent from school, missing at least 10% of school days due to health reasons.” Furthermore, “for each additional traumatic event they endured, their risk of health-related chronic absenteeism rose by 25%, researchers found.” Notably, exposure to violence “was associated with 2.6 times higher odds of chronic absenteeism.” The study was published in Academic Pediatrics.

Related Links:

— “Education Suffers After Even A Single Brush With Childhood Trauma,” Dennis Thompson, HealthDay, June 26, 2025

Black, Hispanic Patients Less Likely To Receive Buprenorphine, Naltrexone After Opioid-Related Healthcare Events, Study Finds

STAT (6/26, Facher, Subscription Publication) reports a study found that “compared to white patients, Black and Hispanic patients were 17.1% and 16.2% less likely, respectively, to receive either buprenorphine or naltrexone within 180 days of a health care event related to their substance use, like a nonfatal overdose or addiction-related infection.” The study is the first to “analyze data from multiple payers at once,” as it includes “data from roughly 176,000 health events related to substance use, and tracks receipt of medication based on claims data from Medicaid programs, Medicare Advantage, and private commercial insurers.” In addition, researchers found that “patients using either of the government-backed insurance options – Medicaid or Medicare Advantage – were substantially more likely to receive buprenorphine or naltrexone than those with commercial insurance.” The study was published in JAMA Network Open.

Related Links:

— “Black, Hispanic patients significantly less likely to receive key addiction medications, study finds,” Lev Facher, STAT, June 26, 2025

Foundation News

John Lion, M.D. Wins 2017 Anti-Stigma Advocacy Award

The Board of Directors of the Maryland Foundation for Psychiatry voted in February to present its 2017 Anti-Stigma Advocacy Award to Dr. John Lion for his piece, “Steadfast talking is the only cure for suicide” published December 18, 2016 in the Baltimore Sun. The board felt it reassured readers that even serious mental illness like depression can be overcome, even if there are setbacks along the way that evoke suicidal thoughts.

The award was established to recognize the article that best fulfills the following goals:

Shares with the public their experience with mental illness in themselves, a family member, or simply in the community.
Helps others to overcome their inability to talk about mental illness or their own mental illness.
Imparts particularly insightful observations on the general subject of mental illness.
A Maryland author and/or newspaper is preferred.

The award carries a $500 prize which the foundation plans to award at the April 27 Maryland Psychiatric Society annual meeting. The 2016 winner was Amy Marlow, whose article “My dad killed himself when I was 13. He hid his depression. I won’t hide mine.” was published February 9, 2016 in the Washington Post.

Amazon Smile Celebrates With Extra Donations For Organizations

Amazon celebrated its #1 ranking in customer satisfaction by the American Customer Satisfaction Index (ACSI) On March 16th, 2017. The ACSI surveyed over 10,000 customers to measure perceptions of quality and value across retailers nationwide. March 16th only, Amazon donated 5% (10 times the usual donation rate) of the price of eligible AmazonSmile purchases to the Maryland Foundation For Psychiatry Inc.

While the amount is lower now, you can still make your purchases count at smile.amazon.com/ch/52-1701356.

New PSA Examines Anxiety from Political and Social Media

The Foundation has released a new Public Service Announcement now playing on local Maryland radio stations. It examines the wide variety of feelings people experience after a particularly divisive political campaign or a significant event getting 24 hour coverage across networks and online. Those feelings can include alienation from family and friends, anger at a system or event out of their control, and grief or helplessness at what may come. There are things that can be done to help, ranging from breaks from Facebook and Twitter and similar sites to seeking actual help from professionals.

Listen to the PSA on our home page or on our PSA collection here, where you can listen to or download other advice given in past PSAs, also.

“This is My Brave” Event Coming December 7

1478645916439

This is my Brave – Baltimore event will be held Wednesday, December 7.
Doors Open at 5 PM – Show starts at 6 PM at Towson University’s West Village Commons, Towson, MD 21252. The Maryland Foundation for Psychiatry is supporting this inspiring, monologue-based production featuring people sharing their stories of living with and recovering from mental illness through original essay, poetry, dance and music.

Foundation Establishes Anti-Stigma Advocacy Award

The Maryland Foundation for Psychiatry has established the Anti-Stigma Advocacy Award. It is designed to recognize a worthy piece published in a major newspaper that accomplishes one or more of the following:

  • Shares with the public their experience with mental illness in themselves, a family member, or simply in the community.
  • Helps others to overcome their inability to talk about mental illness or their own mental illness.
  • Imparts particularly insightful observations on the general subject of mental illness.
  • A Maryland author and/or newspaper is preferred.

The award carries a $500 prize, and has its own dedicated page here.

The winner for 2016 is Amy McDowell Marlow.

“My dad killed himself when I was 13. He hid his depression. I won’t hide mine.”
Published February 9, 2016 in the Washington Post

In this piece, Ms. Marlow gives a very poignant description of dealing with her own depression and emotional experiences beginning in childhood while dealing with a parent’s depression and eventual suicide.